TABLE 2.
Drug | Virus | IC50 (nM) per season
|
Total IC50 (nM)a
|
P valueb | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2004-2005
|
2005-2006
|
2006-2007
|
||||||||||
Range (n) | Mean ± SD | Range (n) | Mean ± SD | Range (n) | Mean ± SD | Range (n) | Mean ± SD | Cutoff | Statistical cutoff | |||
Oseltamivir | A(H1N1) | 0.35-6.05 (53) | 0.96 ± 0.97 | 0.19-10.00 (258) | 1.15 ± 1.01 | 0.16-4.51 (817) | 0.84 ± 0.45 | 0.16-10.00 (1,128) | 0.91 ± 0.66 | 2.89 | 2.43 | <0.0001 |
A(H3N2) | 0.11-3.45 (142) | 0.52 ± 0.34 | 0.08-3.05 (186) | 0.59 ± 0.46 | 0.04-5.16 (908) | 0.40 ± 0.32 | 0.04-5.16 (1,236) | 0.44 ± 0.35 | 1.50 | 1.51 | <0.0001 | |
B | 1.24-11.63 (175) | 3.23 ± 1.63 | 0.70-7.95 (203) | 3.45 ± 1.36 | 0.19-10.48 (511) | 3.47 ± 1.24 | 0.19-11.63 (889) | 3.42 ± 1.35 | 7.47 | 8.64 | 0.122 | |
Zanamivir | A(H1N1) | 0.50-6.48 (53) | 1.12 ± 0.88 | 0.20-13.50 (259) | 1.30 ± 1.34 | 0.06-11.60 (822) | 0.98 ± 0.74 | 0.06-13.50 (1,134) | 1.06 ± 0.93 | 3.85 | 3.32 | <0.0001 |
A(H3N2) | 0.49-13.98 (140) | 3.66 ± 2.51 | 0.14-11.77 (186) | 2.62 ± 2.04 | 0.15-20.00 (907) | 2.35 ± 2.16 | 0.14-20.00 (1,233) | 2.54 ± 2.22 | 9.20 | 9.93 | <0.0001 | |
B | 1.12-16.51 (175) | 4.21 ± 2.65 | 0.85-17.86 (203) | 4.84 ± 2.77 | 0.35-12.00 (511) | 3.36 ± 2.14 | 0.35-17.86 (889) | 3.87 ± 2.47 | 11.29 | 14.21 | <0.0001 |
A total of 3,261 isolates were tested(12 extreme outliers were excluded from the statistical analysis for the respective drug eliciting the outlier IC50s). The cutoff value was determined based on the elected criterion of the mean IC50 value + 3 standard deviations (SD). The statistical cutoff value was determined based on the IC50 value of >X0.75 + 3 IQR.
P value was determined by analysis of variance (where α = 0.05).